Trials / Completed
CompletedNCT00911547
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 2-Period, Parallel-Group Study to Assess the Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 642 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the additive effect of montelukast (MK0476) taken along with inhaled beclomethasone versus inhaled beclomethasone alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | 10 mg tablet taken once daily at bedtime for 16 weeks |
| DRUG | beclomethasone | 200 ug inhaled, taken twice daily for 16 weeks |
| DRUG | Placebo inhaler | placebo inhaler taken twice daily for 16 weeks |
| DRUG | placebo tablet | placebo tablet taken once daily at bedtime for 16 weeks |
Timeline
- Start date
- 1995-03-01
- Primary completion
- 1996-04-01
- Completion
- 1996-05-01
- First posted
- 2009-06-02
- Last updated
- 2022-02-03
- Results posted
- 2010-06-09
Source: ClinicalTrials.gov record NCT00911547. Inclusion in this directory is not an endorsement.